Terms: = Ovarian cancer AND Ki-67
590 results:
1. The Predictive Role of Serum Lipid Levels, p53 and ki-67, According to Molecular Subtypes in Breast cancer: A Randomized Clinical Study.
Faur IF; Dobrescu A; Clim IA; Pasca P; Prodan-Barbulescu C; Tarta C; Neamtu AA; Brebu D; Neamtu C; Rosu M; Duta C; Clim A; Lazar G; Totolici B
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612725
[TBL] [Abstract] [Full Text] [Related]
2. Pre-operative plasma VEGF-C levels portend recurrence in epithelial ovarian cancer patients and is a bankable prognostic marker even in the initial assessment of a patient.
Bhaskari J; Bhagat R; Shilpa V; Premalata CS; Krishnamoorthy L
J Ovarian Res; 2024 Apr; 17(1):77. PubMed ID: 38594780
[TBL] [Abstract] [Full Text] [Related]
3. Post molar choriocarcinoma with solitary renal metastasis in the absence of primary uterine tumor: a case report and review of the literature.
Geravandi M; Hajihashemi A; Adibi A; Habibi Tirtashi R
J Med Case Rep; 2024 Mar; 18(1):132. PubMed ID: 38553733
[TBL] [Abstract] [Full Text] [Related]
4. Podocalyxin promotes the formation of compact and chemoresistant cancer spheroids in high grade serous carcinoma.
Le Tran N; Wang Y; Bilandzic M; Stephens A; Nie G
Sci Rep; 2024 Mar; 14(1):7539. PubMed ID: 38553472
[TBL] [Abstract] [Full Text] [Related]
5. The roles of autophagy, ferroptosis and pyroptosis in the anti-ovarian cancer mechanism of harmine and their crosstalk.
Zhu J; Zhu H; Zhu Q; Xu SL; Xiao L; Zhang MY; Gao J
Sci Rep; 2024 Mar; 14(1):6504. PubMed ID: 38499622
[TBL] [Abstract] [Full Text] [Related]
6. Survival time prediction in patients with high-grade serous ovarian cancer based on
He D; Zhang X; Chang Z; Liu Z; Li B
BMC Cancer; 2024 Mar; 24(1):337. PubMed ID: 38475819
[TBL] [Abstract] [Full Text] [Related]
7. CD47-a novel prognostic predicator in epithelial ovarian cancer and correlations with clinicopathological and gene mutation features.
Luo X; Mo J; Zhang M; Huang W; Bao Y; Zou R; Yao L; Yuan L
World J Surg Oncol; 2024 Feb; 22(1):44. PubMed ID: 38317230
[TBL] [Abstract] [Full Text] [Related]
8. Morphologic and Molecular Heterogeneity of High-grade Serous Carcinoma Precursor Lesions.
Chien YW; Wang Y; Huang P; Lawson BC; Kolin DL; Chui MH; Vang R; Numan TA; Soong TR; Wang BG; Smith SA; Chen CL; Stone R; Douville C; Wang TL; Shih IM
Am J Surg Pathol; 2024 Apr; 48(4):475-486. PubMed ID: 38298022
[TBL] [Abstract] [Full Text] [Related]
9. Optical Genome Mapping Reveals the Landscape of Structural Variations and Their Clinical Significance in HBOC-Related Breast cancer.
Cheng Y; Dong L; Bu D; Han L; Zhao Y; Liu J; Guo X; Xu H; Yu J
Front Biosci (Landmark Ed); 2024 Jan; 29(1):2. PubMed ID: 38287797
[TBL] [Abstract] [Full Text] [Related]
10. [Antitumor effects of redox-responsive nanoparticles containing platinum(Ⅳ)in ovarian cancer].
Hou HY; Tang DS; Zhang YN; Wang KY; Ao M; Luo HX; Li B
Zhonghua Zhong Liu Za Zhi; 2024 Jan; 46(1):76-85. PubMed ID: 38246783
[No Abstract] [Full Text] [Related]
11. Histopathologic and Preneoplastic Changes in Tubal Ligation Materials.
Ömeroğlu E; Ünlü Y; Uğur Kılınç AN; Günler T; Günenc O
Medicina (Kaunas); 2023 Dec; 59(12):. PubMed ID: 38138220
[No Abstract] [Full Text] [Related]
12. Activation of PI3K/AKT/mTOR signaling axis by UBE2S inhibits autophagy leading to cisplatin resistance in ovarian cancer.
Zhang M; Wang J; Guo Y; Yue H; Zhang L
J Ovarian Res; 2023 Dec; 16(1):240. PubMed ID: 38115063
[TBL] [Abstract] [Full Text] [Related]
13. Relationship between PIWIL1 gene polymorphisms and epithelial ovarian cancer susceptibility among southern Chinese woman: a three-center case-control study.
Liu S; Yan Y; Cui Z; Feng H; Zhong F; Liu Z; Li Y; Ou X; Li W
BMC Cancer; 2023 Nov; 23(1):1149. PubMed ID: 38012622
[TBL] [Abstract] [Full Text] [Related]
14. The effect of cuproptosis-relevant genes on the immune infiltration and metabolism of gynecological oncology by multiply analysis and experiments validation.
Ran XM; Xiao H; Tang YX; Jin X; Tang X; Zhang J; Li H; Li YK; Tang ZZ
Sci Rep; 2023 Nov; 13(1):19474. PubMed ID: 37945610
[TBL] [Abstract] [Full Text] [Related]
15. Survey of clinicians on the use of adjuvant therapy for premenopausal women with breast cancer.
Lee YW; Ahn SH; Lee YJ; Yoo TK; Kim J; Chung IY; Kim HJ; Ko BS; Lee JW; Son BH; Lee SB
PLoS One; 2023; 18(8):e0290174. PubMed ID: 37590284
[TBL] [Abstract] [Full Text] [Related]
16. Fortuitously detected primary ovarian carcinoid tumor: A case report.
Choi HY; Pak MG; Park JW
Medicine (Baltimore); 2023 Aug; 102(31):e34391. PubMed ID: 37543794
[TBL] [Abstract] [Full Text] [Related]
17. Clinicopathological analysis of patients with molecularly confirmed stage I adult granulosa cell tumors and prediction of recurrence.
Liu Y; Chen J; Lu Z; Chang X; Wang P; Ma H; Chen X; Mo S; Lv Z; Mao X; Zong L; Yu S; Chen J
Gynecol Oncol; 2023 Sep; 176():106-114. PubMed ID: 37481922
[TBL] [Abstract] [Full Text] [Related]
18. [Clinicopathological analysis of pseudostratified ependymal tubules in ovarian mature teratoma].
Xiao XL; Huang YX; Chen JM; Liu SG; Mo RM; Lai LZ
Zhonghua Bing Li Xue Za Zhi; 2023 Jul; 52(7):678-682. PubMed ID: 37408397
[No Abstract] [Full Text] [Related]
19. Pathological discrimination between luteinized thecoma associated with sclerosing peritonitis and thecoma.
Liu J; Wei J; Yang Y; Wei J
Medicine (Baltimore); 2023 Jun; 102(23):e33911. PubMed ID: 37335673
[TBL] [Abstract] [Full Text] [Related]
20. FOXM1 Contributes to Chemotherapy Sensitivity in Cervical cancer by Regulating TTK.
Tang Q; Xu A; Yang Y; Zhang Y; Sun J
Discov Med; 2023 Jun; 35(176):208-220. PubMed ID: 37272088
[TBL] [Abstract] [Full Text] [Related]
[Next]